On Friday, Hims & Hers Health Inc (NYSE: HIMS) was 6.43% up from the session before settling in for the closing price of $54.87. A 52-week range for HIMS has been $16.05 – $72.98.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 17.22%. When this article was written, the company’s average yearly earnings per share was at 7.72%. With a float of $202.64 million, this company’s outstanding shares have now reached $217.38 million.
Hims & Hers Health Inc (HIMS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Hims & Hers Health Inc stocks. The insider ownership of Hims & Hers Health Inc is 10.34%, while institutional ownership is 77.76%. The most recent insider transaction that took place on Sep 24 ’25, was worth 118,692. In this transaction Chief Commercial Officer of this company sold 2,100 shares at a rate of $56.52, taking the stock ownership to the 291,439 shares. Before that another transaction happened on Sep 22 ’25, when Company’s Chief Financial Officer sold 23,584 for $57.74, making the entire transaction worth $1,361,766. This insider now owns 105,400 shares in total.
Hims & Hers Health Inc (HIMS) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.43 earnings per share (EPS) during the time that was better than consensus figure (set at 0.15) by 0.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.47% during the next five years compared to 17.22% growth over the previous five years of trading.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
You can see what Hims & Hers Health Inc (HIMS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.56. Likewise, its price to free cash flow for the trailing twelve months is 113.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.80, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.79 in one year’s time.
Technical Analysis of Hims & Hers Health Inc (HIMS)
Compared to the last year’s volume of 32.93 million, its volume of 22.78 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 63.89%.
During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 62.66%, which indicates a significant decrease from 91.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.79 in the past 14 days, which was lower than the 3.97 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.38, while its 200-day Moving Average is $43.26. Nevertheless, the first resistance level for the watch stands at $59.83 in the near term. At $61.26, the stock is likely to face the second major resistance level. The third major resistance level sits at $64.12. If the price goes on to break the first support level at $55.54, it is likely to go to the next support level at $52.68. Should the price break the second support level, the third support level stands at $51.25.
Hims & Hers Health Inc (NYSE: HIMS) Key Stats
There are 226,020K outstanding shares of the company, which has a market capitalization of 13.20 billion. As of now, sales total 1,477 M while income totals 126,040 K. Its latest quarter income was 544,830 K while its last quarter net income were 42,510 K.
